# Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant

> **NCT00639171** · — · COMPLETED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 3 (actual)

## Conditions studied

- Breast Tumors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00639171
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2023-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00639171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00639171, "Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00639171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*